Pfizer’s Two New R&D Heads: The Fit Is "Extraordinary”

In their first joint interview since announcing the new leadership structure of a bulked-up Pfizer, Martin Mackay and Mikael Dolsten, speak candidly about their R&D initiatives.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet